The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Neuroinflammation in Alzheimer's Disease and Mild Cognitive Impairment: A Field in Its Infancy
Abstract
Neuroinflammation is a prominent feature of Alzheimer disease (AD) and other chronic neurodegenerative disorders. It exacerbates the fundamental pathology by generating a plethora of inflammatory mediators and neurotoxic compounds. Inflammatory cytokines, complement components, and toxic free radicals are among the many species that are generated. Microglia attack the pathological entities and may inadvertently injure host neurons. Recent evidence indicates that microglia can be stimulated to assume an antiinflammatory state rather than a proinflammatory state which may have therapeutic potential. Proinflammatory cytokines include IL-1, IL-6 and TNF, while antiinflammatory cytokines include IL-4 and IL-10. Complement activation is a separate process which causes extensive neuronal damage in AD through assembly of the membrane attack complex. Aggregated amyloid-beta is a potent activator of human complement but not of mouse complement. This is an important difference between AD and transgenic mouse models of AD. Many so far unexplored molecules may contribute to neuroinflammation or act to inhibit it. Stable isotope labeling by amino acids in cell culture (SILAC) analysis identified 174 proteins that were upregulated by two-fold or more, and 189 that were downregulated by 2-fold or more following inflammatory stimulation of microglial-like THP-1 cells. Neurotoxicity may result from any combination of these and further exploration is clearly warranted. In addition, many small molecules may play a significant role. One example is hydrogen sulfide which appears to be an endogenous antiinflammatory agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
The possible role of hydrogen sulfide as an endogenous neuromodulator
Abe, K., & Kimura, H. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01066.1996 · Cited by 2,239
Hydrogen sulphide and its therapeutic potential
Szabó, C. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2425 · Cited by 2,038
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961 · cited 1×
“fold [35–38].”
Reactive astrocytes: cellular and molecular cues to biological function
Ridet, J. L., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766
Bal-Price, A., & Brown, G. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06480.2001 · Cited by 686
Watson, G. S. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 597
Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists.
Łowicka, E., & Bełtowski, J. (2007) · PubMed · Cited by 557
Cytokine Actions in the Central Nervous System
Benveniste, E. N. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00015-x · Cited by 383
Butovsky, O., Talpalar, A. E., Ben-Yaakov, K., & Schwartz, M. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.03.005 · Cited by 365
Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative
Li, L., Rossoni, G., Sparatore, A., Lee, L. C., Del Soldato, P., & Moore, P. K. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.12.011 · Cited by 345
Maier, M., Peng, Y., Jiang, L., Seabrook, T. J., Carroll, M. C., & Lemere, C. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0829-08.2008 · Cited by 323 · cited 1×
“When complement C3 deficient mice were crossed with amyloid-β protein precursor (AβPP) overexpressing mice, there was an acceleration of amyloid plaque deposition with enhanced neuronal loss [34].”
Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism
Chao, C. C., Hu, S., Sheng, W. S., Bu, D., Bukrinsky, M. I., & Peterson, P. K. (1996) · Glia · doi:10.1002/(sici)1098-1136(199603)16:3<276::aid-glia10>3.0.co;2-x · Cited by 272
The significance of neuroinflammation in understanding Alzheimer’s disease
Eikelenboom, P., Veerhuis, R., Scheper, W., Rozemuller, A. J. M., van Gool, W. A., & Hoozemans, J. J. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0575-6 · Cited by 262
Hydrogen sulfide: Neurochemistry and neurobiology
Qu, K., Lee, S. W., Bian, J. S., Low, C.-M., & Wong, P. T.-H. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2007.05.016 · Cited by 259
Sokolova, A., Hill, M. D., Rahimi, F., Warden, L. A., Halliday, G. M., & Shepherd, C. E. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00188.x · Cited by 249
Current View on the Mononuclear Phagocyte System
Van Furth, R. (1982) · Immunobiology · doi:10.1016/s0171-2985(82)80072-7 · Cited by 245
Inflammatory Aspects of Alzheimer Disease and Other Neurodegenerative Disorders
Schwab, C., & McGeer, P. L. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13402 · Cited by 234
Self-citationVukic, V., Callaghan, D., Walker, D., Lue, L.-F., Liu, Q. Y., Couraud, P.-O., Romero, I. A., Weksler, B., Stanimirovic, D. B., & Zhang, W. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.12.007 · Cited by 232 · cited 1×
“The upregulation of genes for cytokines such as MCP-1, IL-1 β , and IL-6 in human brain endothelial cells and in AD brain is reportedly mediated by the JNK-AP1 signaling pathway [45].”
Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide
Lee, M., Schwab, C., Yu, S., McGeer, E., & McGeer, P. L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.06.001 · Cited by 203
Self-citationThe Brain as a Target for Inflammatory Processes and Neuroprotective Strategies
SKAPER, S. D. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1403.002 · Cited by 192
Imaging Neuroinflammation in Alzheimer's Disease with Radiolabeled Arachidonic Acid and PET
Esposito, G., Giovacchini, G., Liow, J.-S., Bhattacharjee, A. K., Greenstein, D., Schapiro, M., Hallett, M., Herscovitch, P., Eckelman, W. C., Carson, R. E., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.049619 · Cited by 183
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology
Hoozemans, J. J. M., Veerhuis, R., Rozemuller, J. M., & Eikelenboom, P. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.001 · Cited by 168
Herber, D. L., Mercer, M., Roth, L. M., Symmonds, K., Maloney, J. L., Wilson, N., Freeman, M. J., Morgan, D., & Gordon, M. N. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9069-z · Cited by 167
Downen, M., Amaral, T. D., Hua, L. L., Zhao, M., & Lee, S. C. (1999) · Glia · doi:10.1002/(sici)1098-1136(199911)28:2<114::aid-glia3>3.0.co;2-o · Cited by 158
Thornton, P., Pinteaux, E., Gibson, R. M., Allan, S. M., & Rothwell, N. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03872.x · Cited by 152
Tan, J. R., Town, T., Mori, T., Wu, Y., Saxe, M., Crawford, F., & Mullan, M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07587.2000 · Cited by 138
Padmanabhan, J., Levy, M. M., Dickson, D. W., & Potter, H. (2006) · Brain · doi:10.1093/brain/awl255 · Cited by 137
Stewart, V. C., Sharpe, M. A., Clark, J. B., & Heales, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750694.x · Cited by 134
Evidence for an inflammatory process in age-related macular degeneration gains new support
Bok, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502819102 · Cited by 129
Venneti, S., Wang, G., Nguyen, J., & Wiley, C. A. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318188b204 · Cited by 129
Interferon-γ-dependent cytotoxic activation of human astrocytes and astrocytoma cells
Hashioka, S., Klegeris, A., Schwab, C., & McGeer, P. L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.019 · Cited by 111
Self-citationLee, M., Sparatore, A., Soldato, P. D., McGeer, E. G., & McGeer, P. L. (2009) · Glia · doi:10.1002/glia.20905 · Cited by 106
Self-citationThe Effects of NOS2 Gene Deletion on Mice Expressing Mutated Human AβPP
Colton, C. A., Wilcock, D. M., Wink, D. A., Davis, J., Nostrand, W. E. V., & Vitek, M. P. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15405 · Cited by 102
Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer’s disease
Popp, J., Bacher, M., Kölsch, H., Noelker, C., Deuster, O., Dodel, R. C., & Jessen, F. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.10.006 · Cited by 99
Gulyás, B. Z., Makkai, B., Kása, P., Gulya, K., Bakota, L., Várszegi, S., Beliczai, Z., Andersson, J. D., Csiba, L., Thiele, A., et al. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.001 · Cited by 85
Role of activated astrocytes in neuronal damage: Potential links to HIV-1-associated dementia
Deshpande, M. S., Zheng, J., Borgmann, K., Persidsky, R., Wu, L., Schellpeper, C. N., & Ghorpade, A. (2005) · Neurotoxicity Research · doi:10.1007/bf03036448 · Cited by 80
Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease
Bossù, P., Ciaramella, A., Moro, M. L., Bellincampi, L., Bernardini, S., Federici, G., Trequattrini, A., Macciardi, F. M., Spoletini, I., Iulio, F. D., et al. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.103242 · Cited by 68
Sparing of age-related macular degeneration in rheumatoid arthritis
McGeer, P. L., & Sibley, J. T. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.02.003 · Cited by 54
Self-citationMizuno, T., Kuno, R., Nitta, A., Nabeshima, T., Zhang, G., Kawanokuchi, J., Wang, J., Jin, S., Takeuchi, H., & Suzumura, A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.10.050 · Cited by 52
Hashioka, S., Klegeris, A., & McGeer, P. L. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.02.002 · Cited by 41
Self-citationIs there a future for vaccination as a treatment for Alzheimer's disease?
McGeer, P. L., & McGeer, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00157-4 · Cited by 39
Self-citationKlegeris, A., Li, J., Bammler, T. K., Jin, J., Zhu, D. C., Kashima, D. T., Pan, S., Hashioka, S., Maguire, J. A., McGeer, P. L., et al. (2008) · Glia · doi:10.1002/glia.20645 · Cited by 39
Self-citationWang, B., Zhou, S., Yang, Z., Xie, Y., Wang, J., Zhang, P., Lv, Z., Zheng, C., & Ma, X. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.02.021 · Cited by 30
Genetic Analysis of Interleukin-1A C(-889)T Polymorphism with Alzheimer Disease
Hu, J.-L., Li, G., Zhou, D., Zou, Y., Zhu, Z., Xu, R., Jiang, X., & Zeng, Y. (2008) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-008-9299-5 · Cited by 17
Type 2 Diabetes: Local Inflammation and Direct Effect of Bacterial Toxic Components
Miklossy, J., Martins, R. N., Darbinian, N., Khalili, K., & McGeer, P. L. (2008) · The Open Pathology Journal · doi:10.2174/1874375700802010086 · Cited by 14
Self-citation
Cited by
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
Condello, C., Yuan, P., Schain, A., & Grutzendler, J. (2015) · Nature Communications · doi:10.1038/ncomms7176 · Cited by 718
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583
Deckers, K., van Boxtel, M. P. J., Schiepers, O. J. G., de Vugt, M., Muñoz Sánchez, J. L., Anstey, K. J., Brayne, C., Dartigues, J.-F., Engedal, K., Kivipelto, M., et al. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4245 · Cited by 534
The outdoor air pollution and brain health workshop
Block, M. L., Elder, A., Auten, R. L., Bilbo, S. D., Chen, H., Chen, J.-C., Cory-Slechta, D. A., Costa, D., Diaz-Sanchez, D., Dorman, D. C., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.08.014 · Cited by 539
Metadata
- Authors
- McGeer, E. G., & McGeer, P. L.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-01-06
- Volume
- 19
- Issue
- 1
- Pages
- 355-361
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1812789667
- Cited by
- 346
- References
- 51
- FWCI
- 14.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.